ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARAY Accuray Incorporated

1.64
0.10 (6.49%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Accuray Incorporated NASDAQ:ARAY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 6.49% 1.64 1.60 2.12 1.62 1.54 1.60 1,537,411 05:00:05

Accuray To Report Fiscal 2017 First Quarter Financial Results On October 27, 2016

06/10/2016 9:05pm

PR Newswire (US)


Accuray (NASDAQ:ARAY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Accuray Charts.

SUNNYVALE, Calif., Oct. 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal first quarter ended September 30, 2016 on Thursday, October 27, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

Accuray Incorporated

The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week.  The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 94520436.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at www.accuray.com/investors.  A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2017, ending December 31, 2016.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com

Contacts:




Investors:

Brian Moore, EVC Group, 310-770-0389, bmoore@evcgroup.com


Doug Sherk, EVC Group, 415-652-9100, dsherk@evcgroup.com



Media:

Beth Kaplan


Public Relations Director, Accuray


408-789-4426


bkaplan@accuray.com

Logo - http://photos.prnewswire.com/prnh/20160108/320376LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2017-first-quarter-financial-results-on-october-27-2016-300340811.html

SOURCE Accuray Incorporated

Copyright 2016 PR Newswire

1 Year Accuray Chart

1 Year Accuray Chart

1 Month Accuray Chart

1 Month Accuray Chart

Your Recent History

Delayed Upgrade Clock